Moreover, we demonstrated that in vivo Saa3-promoter bioluminescence imaging is a sensitive and specific tool for detecting and visualizing tubulointerstitial injury in real-time in living animals with repeated low-dose AA and CIS treatment. Here, SAA3P is linked to in situ carcinoma.